Topic: mergers and acquisitions
Amag Pharma has struck a merger deal with Perosphere, adding an anticoagulant reversal agent in midstage trials to its emerging hematology business.
10x Genomics is making moves into the emerging field of tissue genomics by buying Spatial Transcriptomics and its location-based mRNA analysis tools.
The acquisition is expected to bolster Biotage’s presence as a separations company within the growing biomolecule arena.
ResMed is acquiring Propeller Health in a $225 million deal to broaden the reach of its connected respiratory devices across all stages of COPD.
Medtronic plans to absorb Nutrino Health, a nutrition-focused data analytics company, and further integrate its work with its diabetes group.
WuXi NextCODE acquired Genomics Medicine Ireland as part of a $400 million investment.
Specialized implant manufacturer ChoiceSpine was acquired by Altus Capital Partners, marking the firm’s second medtech acquisition in two years.
San Diego and North Carolina-based Synteract has acquired specialty pediatric CRO KinderPharm for an undisclosed price.
Boston Scientific has moved to absorb BTG for $4.2 billion in cash, acquiring a pipeline that could transform its oncology franchise.
News of the merger comes as Enlivex gears up for a multi-indication phase 2 and 3 trial push for its immunotherapy Allocetra.